Yang Zhou

4.7k total citations
157 papers, 3.0k citations indexed

About

Yang Zhou is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Yang Zhou has authored 157 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 35 papers in Epidemiology and 25 papers in Infectious Diseases. Recurrent topics in Yang Zhou's work include Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (19 papers) and Protein Degradation and Inhibitors (11 papers). Yang Zhou is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (19 papers) and Protein Degradation and Inhibitors (11 papers). Yang Zhou collaborates with scholars based in China, United States and Sweden. Yang Zhou's co-authors include Xiaoyun Lu, Yanlin Zhao, Ke Ding, Shengfen Wang, Li He, Meng‐Tian Kang, Shi‐Ming Li, Luo-Ru Liu, Guoyin Kai and Changping Deng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Yang Zhou

143 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Zhou China 32 1.2k 864 452 406 356 157 3.0k
Dongli Li China 30 1.3k 1.1× 258 0.3× 142 0.3× 101 0.2× 116 0.3× 255 4.0k
Li Su China 28 1.2k 1.0× 452 0.5× 146 0.3× 495 1.2× 46 0.1× 210 3.5k
Xiaomei Zhang China 25 596 0.5× 126 0.1× 93 0.2× 614 1.5× 72 0.2× 124 2.2k
Wenji Zhang China 32 1.2k 1.0× 228 0.3× 108 0.2× 78 0.2× 69 0.2× 110 2.8k
Honggang Zhou China 32 1.6k 1.3× 248 0.3× 52 0.1× 334 0.8× 46 0.1× 139 3.4k
Guang‐Biao Zhou China 41 4.3k 3.6× 256 0.3× 83 0.2× 109 0.3× 49 0.1× 133 6.3k
Feifei Chen China 29 1.7k 1.4× 161 0.2× 84 0.2× 608 1.5× 24 0.1× 181 3.6k
Yashpal S. Chhonker United States 25 809 0.7× 100 0.1× 73 0.2× 189 0.5× 137 0.4× 108 2.1k
Rajesh Arora India 29 1.0k 0.9× 183 0.2× 362 0.8× 68 0.2× 54 0.2× 225 3.8k
Sven Baumann Germany 34 2.1k 1.7× 397 0.5× 70 0.2× 133 0.3× 20 0.1× 89 3.9k

Countries citing papers authored by Yang Zhou

Since Specialization
Citations

This map shows the geographic impact of Yang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Zhou more than expected).

Fields of papers citing papers by Yang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Zhou. The network helps show where Yang Zhou may publish in the future.

Co-authorship network of co-authors of Yang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Zhou. A scholar is included among the top collaborators of Yang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Zhou. Yang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yayuan, Jie Wang, Ping Zhang, et al.. (2025). The design and synthesis of selective and potent selenium-containing KRASG12D inhibitors. European Journal of Medicinal Chemistry. 298. 118004–118004.
2.
Wang, Xuan, Yong Li, Peishan Li, et al.. (2025). Cell‐Active, Irreversible Covalent Inhibitors Targeting a Surface‐Exposed Non‐Catalytic Lysine on Aurora a Kinase by Using Squarate Chemistry. Angewandte Chemie International Edition. 64(40). e202510763–e202510763.
3.
Ding, Ke, Yupeng Li, Yang Zhou, & Weixue Huang. (2025). Chemical Adaptation in Drug Discovery: The Medicinal Chemistry Journey of Olverembatinib and Limertinib in Overcoming Kinase Drug Resistance. Accounts of Chemical Research. 58(20). 3195–3209.
4.
Chang, Yu‐Sun, Weixue Huang, Wenyan Liu, et al.. (2025). Discovery of YJZ5118: A Potent and Highly Selective Irreversible CDK12/13 Inhibitor with Synergistic Effects in Combination with Akt Inhibition. Journal of Medicinal Chemistry. 68(6). 6718–6734.
5.
Yang, Bowen, Yuan Tian, Yang Zhou, et al.. (2025). Discovery of BW710 as a potent, selective and orally bioavailable fibroblast growth factor receptor 2 (FGFR2) inhibitor. European Journal of Medicinal Chemistry. 287. 117339–117339. 2 indexed citations
6.
Duan, Liping, Weixue Huang, Jiangnan Zheng, et al.. (2025). O-Cyanobenzaldehydes Irreversibly Modify Both Buried and Exposed Lysine Residues in Live Cells. Journal of the American Chemical Society. 147(14). 11955–11963. 5 indexed citations
7.
Chen, Xiaofei, Yu Song, Yiling Liu, et al.. (2024). A near-infrared emitting “off-on” fluorescent probe for bioimaging of Pd(Ⅱ) ions in living cells and mice. Analytica Chimica Acta. 1289. 342174–342174. 5 indexed citations
8.
Liu, Dongxin, Bing Zhao, Zheng Yang, et al.. (2024). Characterization of isoniazid resistance and genetic mutations in isoniazid-resistant and rifampicin-susceptible Mycobacterium tuberculosis in China. SHILAP Revista de lepidopterología. 3(3). 100129–100129. 4 indexed citations
9.
Wang, Jie, Yongjin Wang, Xiaojuan Song, et al.. (2023). Structure-Based Optimization of the Third Generation Type II Macrocycle TRK Inhibitors with Improved Activity against Solvent-Front, xDFG, and Gatekeeper Mutations. Journal of Medicinal Chemistry. 66(18). 12950–12965. 10 indexed citations
10.
Li, Chungen, Yuanyuan Qiao, Xia Jiang, et al.. (2023). Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve. Journal of Medicinal Chemistry. 66(17). 12432–12445. 10 indexed citations
11.
Xia, Hui, Yuanyuan Song, Zheng Yang, et al.. (2022). Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations: Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing. Dove Medical Press (Taylor and Francis Group). 12 indexed citations
12.
Zhang, Yunong, Peng Xia, Jian Zou, et al.. (2022). Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors. Journal of Medicinal Chemistry. 65(22). 15374–15390. 15 indexed citations
13.
Wang, Yongjin, Yang Zhou, Chaowei Shi, et al.. (2022). A toxin-deformation dependent inhibition mechanism in the T7SS toxin-antitoxin system of Gram-positive bacteria. Nature Communications. 13(1). 6434–6434. 7 indexed citations
14.
Zhang, Zhen, Jie Li, Jing Huang, et al.. (2022). Design, Synthesis, and Biological Evaluation of 2-Formyl Tetrahydronaphthyridine Urea Derivatives as New Selective Covalently Reversible FGFR4 Inhibitors. Journal of Medicinal Chemistry. 65(4). 3249–3265. 14 indexed citations
15.
Lai, Mengzhen, Tao Zhang, Yuqing Chen, et al.. (2022). Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations. Journal of Medicinal Chemistry. 65(9). 6840–6858. 43 indexed citations
16.
Song, Xiaojuan, Chong Lei, Xiaoqiang He, et al.. (2022). Discovery of Hexahydrofuro[3,2-b]furans as New Kinase-Selective and Orally Bioavailable JAK3 Inhibitors for the Treatment of Leukemia Harboring a JAK3 Activating Mutant. Journal of Medicinal Chemistry. 65(15). 10674–10690. 6 indexed citations
17.
Zhou, Yang, et al.. (2021). Unveiling the “invisible” druggable conformations of GDP-bound inactive Ras. Proceedings of the National Academy of Sciences. 118(11). 14 indexed citations
18.
Ding, Junmei, Yang Zhou, Chaofan Wang, et al.. (2020). Development of a whole-cell biocatalyst for diisobutyl phthalate degradation by functional display of a carboxylesterase on the surface of Escherichia coli. Microbial Cell Factories. 19(1). 114–114. 26 indexed citations
19.
20.
Zhou, Yang, Rongfeng Zou, Guanglin Kuang, et al.. (2019). Enhanced Sampling Simulations of Ligand Unbinding Kinetics Controlled by Protein Conformational Changes. Journal of Chemical Information and Modeling. 59(9). 3910–3918. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dongli Li Breakdown of academic impact, for papers by Li Su Breakdown of academic impact, for papers by Xiaomei Zhang Breakdown of academic impact, for papers by Wenji Zhang Breakdown of academic impact, for papers by Honggang Zhou Breakdown of academic impact, for papers by Guang‐Biao Zhou Breakdown of academic impact, for papers by Feifei Chen Breakdown of academic impact, for papers by Yashpal S. Chhonker Breakdown of academic impact, for papers by Rajesh Arora Breakdown of academic impact, for papers by Sven Baumann
Rankless by CCL
2026